Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease

Completed

Plain-English translation of NCT01584440 on ClinicalTrials.gov ↗ · Source last updated November 2021 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(44 sites)

United States

Phoenix, Arizona

Sun City, Arizona

Fresno, California

Fullerton, California

Los Angeles, California